| 前收市價 | 41.32 |
| 開市 | 41.70 |
| 買盤 | 36.10 |
| 賣出價 | 39.40 |
| 拍板 | 170.00 |
| 到期日 | 2025-01-17 |
| 今日波幅 | 41.32 - 41.70 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 129 |
Insider MonkeyAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcript May 2, 2024 Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.52272, expectations were $-0.75. ALNY isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
ZacksAlnylam (ALNY) Q1 Loss Narrower Than Expected, Sales Rise Y/Y
Alnylam (ALNY) reports better-than-expected first-quarter 2024 results as both earnings and revenues beat estimates, primarily driven by strong Amvuttra sales.
ZacksCompared to Estimates, Alnylam (ALNY) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Alnylam (ALNY) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
